Metformin reduces systemic methylglyoxal levels in type 2 diabetes.
Year: 1999
Type: article
Study design: Observational Study
Source: Diabetes
Institution: Dartmouth–Hitchcock Medical Center
Language: English
Subfield: Clinical Biochemistry
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2113746520
